I have been in the investment business for a long time, and when I found Cytodyn, it was like, WTH! You cannot use standard multiples in the game; Most BP has only one drug that treats one disease. We have a miracle molecule that the FDA has never dealt with before, meaning Leronlimab treats almost everything.
This is what the FDA is most probably saying.
What if we ok the drug and we might not have a job because it will put our future employer out of business? Billions will be lost, and this is what is going on.